Twin Capital Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$789K Sell
3,516
-6
-0.2% -$1.5K 0.1% 194
2025
Q4
$848K Sell
3,522
-305
-8% -$78K 0.11% 175
2025
Q3
$1.05M Sell
3,827
-2,151
-36% -$588K 0.13% 148
2025
Q2
$1.54M Buy
5,978
+2,219
+59% +$529K 0.16% 145
2025
Q1
$841K Buy
3,759
+200
+6% +$46.7K 0.1% 187
2024
Q4
$814K Buy
3,559
+1,877
+112% +$452K 0.09% 188
2024
Q3
$411K Sell
1,682
-81
-5% -$18.1K 0.05% 257
2024
Q2
$337K Buy
+1,763
New +$358K 0.04% 251
2019
Q4
Sell
-3,480
Closed -$470K 276
2019
Q3
$470K Sell
3,480
-2,100
-38% -$275K 0.03% 253
2019
Q2
$681K Sell
5,580
-15,800
-74% -$1.75M 0.05% 229
2019
Q1
$2.22M Sell
21,380
-50
-0.2% -$5.16K 0.11% 214
2018
Q4
$2.44M Hold
21,430
0.14% 184
2018
Q3
$2.47M Buy
+21,430
New +$2.35M 0.11% 211
2014
Q2
Sell
-17,200
Closed -$769K 309
2014
Q1
$769K Sell
17,200
-1,220
-7% -$54.8K 0.08% 246
2013
Q4
$867K Sell
18,420
-7,990
-30% -$404K 0.09% 237
2013
Q3
$1.4M Sell
26,410
-10,370
-28% -$503K 0.15% 189
2013
Q2
$1.66M Buy
+36,780
New +$1.75M 0.18% 152

Other funds holding RMD

Twin Capital Management's RMD Position: Q1 2026 in Review

Twin Capital Management reduced its ResMed (RMD) stake by 0.17% in Q1 2026, selling an estimated $1.5K and leaving 3,516 shares worth $789K. The position accounts for 0.1% of the portfolio, ranked #194.

Twin Capital Management first reported a position in RMD in Q2 2013 and has held it in 17 quarters since. The position peaked at $2.47M in Q3 2018. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Twin Capital Management held 3,516 shares of ResMed worth $789K as of Q1 2026.
  • Twin Capital Management sold 6 ResMed shares in Q1 2026, an estimated $1.5K.
  • ResMed made up 0.1% of Twin Capital Management's portfolio in Q1 2026, its #194 holding.
  • Twin Capital Management first reported a position in ResMed in Q2 2013 and has held it in 17 quarters since.
  • Twin Capital Management's ResMed position peaked at $2.47M in Q3 2018.
  • 939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Twin Capital Management's 13F filing for Q1 2026, filed 5 May 2026.